Introduction
Cardiovascular disease in pregnancy is the most common cause of nonobstetric maternal mortality [1] . Substantial changes, such as increases in cardiac output (40-50%) and blood volume (40%), occur in the cardiovascular system during pregnancy, whereas systemic peripheral resistance and arterial pressure decrease [2] . These changes may cause left ventricular outflow tract obstruction [3] . In pregnancy with both aortic stenosis and insufficiency, left ventricular outflow is more limited. Fixed left ventricular outflow tract obstruction causes a restriction of stroke volume and cardiac output in pregnancy. In addition, anxiety, exertion and the pain of labor and delivery increase the hemodynamic stress on the cardiovascular system and may trigger cardiovascular decompensation. Pregnant women with both aortic stenosis and insufficiency are therefore at increased risk of cardiovascular complications, including heart failure, cardiac collapse and death. Aortic insufficiency is well tolerated in pregnancy, but aortic stenosis may become symptomatic and clinically significant [4] . Cardiac output depends entirely on heart rate and preload in aortic stenosis. In other words, cardiac output cannot be increased by the usual physiologic mechanisms of greater stroke volume, because the effective aortic valve area is smaller than nor- mal. Therefore, both tachycardia and bradycardia must be avoided, and adequate preload must be maintained during labor in such patients. In addition, inferior vena caval compression and prolonged efforts at pushing in the second stage of labor may occlude venous return and reduce preload and cardiac output.
Aortic insufficiency is rarely symptomatic in pregnant patients. Chronic volume overload of the left ventricle results in hypertrophy and dilatation. Pain, with resultant increases in vascular resistance and bradycardia that will increase the time for regurgitant flow, must be avoided in aortic insufficiency during labor. Since vaginal delivery may cause undesirable effects of pain and Valsalva maneuver, cesarean section is usually recommended in such cases. We report a case of successful vaginal delivery in a cardiac patient.
Case Report
A 26-year-old primigravid patient with severe aortic stenosis and aortic insufficiency was admitted to the Obstetric Service. She had suffered rheumatic fever at 6 years of age, with aortic valve disease being diagnosed the following year. She had no history of medication other than endocarditis prophylaxis with depot penicillin.
The patient had a history of weakness, dizziness and shortness of breath, especially increased in frequency after 30 weeks of gestation. Her last menstruation was 39 weeks and 6 days prior, so that the expected date of delivery would be 2 days hence. She experienced 2 syncopal episodes in the last trimester. Cardiologic examination revealed paroxysmal sinus tachycardia up to 130 beats/min, and palpitations precipitated by walking or climbing stairs. Electrocardiogram demonstrated left ventricular hypertrophy ( fig. 1 ) . A transthoracic echocardiogram demonstrated severe left ventricular dilatation and hypertrophy, diastolic interventricular septum diameter of 16 mm, left ventricular end-diastolic diameter of 55 mm, aortic valve area of 0.8 cm 2 , mean aortic gradient of 48 mm Hg, and left ventricular ejection fraction of 55%. Arterial blood pressure (BP) was 125/50 mm Hg and heart rate was 92 beats/min.
Initially, the obstetrician recommended cesarean section in order to avoid cardiovascular decompensation by sympathetic activation during vaginal delivery, but the patient preferred vaginal delivery if possible. Therefore, low-dose epidural analgesia was planned after consultation with the cardiologist, obstetrician and patient. The delivery room was prepared for the patient. Required equipment (defibrillation, central venous and pulmonary arterial catheterization, invasive arterial monitorization, intubation, resuscitation, mechanical ventilation facilities) was provided.
The patient had irregular contractions, and was admitted to the delivery room at 40 weeks + 2 days of gestation. Low-dose oxytocin (1-2 mIU/min) infusion was administered to the patient for induction. Electrocardiography, pulse oximetry and invasive radial arterial BP monitoring were established. An epidural catheter was placed uneventfully at the L 3-4 lumbar interspace while the patient was in the left lateral position. At 4 cm cervical dilatation, 10 ml of 0.125% ropivacaine and 20 g fentanyl were administered via an epidural catheter over 10 min, and a further 500 ml of isotonic saline was then given intravenously over 30 min to prevent likely hypotension due to epidural block. Hypotension was considered to be systolic BP ! 80 mm Hg. In case of the development of hypotension, ephedrine treatment was planned with incremental 5-mg doses.
Adequate analgesia was established at T 10 dermatome without motor block. One hour later, an infusion of 0.125% ropivacaine with 1 g/ml of fentanyl was initiated at 10 ml/h and titrated between 8 and 12 ml/h as labor progressed. The patient remained comfortable with a heart rate of 70-95 beats/min, systolic BP 1 100 mm Hg and oxygen saturation 1 97% throughout labor. She was not allowed prolonged efforts to push in the second stage to prevent occluding venous return and reducing preload and cardiac output. After 5 h, the patient reached complete cervical dilatation. The second stage of labor lasted 25 min and then a 3,200-gram boy, with Apgar scores of 8 and 10 at 1 and 5 min, respectively, was delivered without any obstetric intervention. Ten international units of oxytocin were administered as an infusion in 500 ml of isotonic saline over 1 h. The placenta was delivered spontaneously 20 min after delivery. Hypotension did not occur during labor and ephedrine was not needed. Breast feeding was started spontaneously without any problem. The patient was observed closely for 2 days during the postpartum period and then discharged with suggestions about contraception.
Discussion
Maternal mortality may be increased in cases with severe aortic valve disease [5] . Cesarean section is usually performed for cardiac patients to avoid undesirable effects of pain and the marked Valsalva effect of prolonged efforts at pushing in the second stage [6, 7] .
The use of neuroaxial block in patients with clinically significant cardiac disease is a controversial issue because [8, 9] . Traditionally, epidural anesthesia or analgesia is considered to be contraindicated in cardiovascular disease because of excessive peripheral vasodilatation and hypotension with a fixed cardiac output. Hypotension in these patients can theoretically produce myocardial ischemia and tachycardia leading to increasing myocardial oxygen consumption and reducing left ventricular filling time. However, there are differing opinions regarding the safest management of labor and delivery for such patients.
Since epidural analgesia reduces catecholamine release and hemodynamic stress, it has frequently been used of late in diluted forms for vaginal delivery in these patients. Suntharalingam et al. [3] used the low-dose technique with a 0.1% bupivacaine and fentanyl combination in their 5-case series. They concluded that epidural analgesia may be used for delivery in aortic stenosis with close invasive monitoring. We also used 0.125% ropicaine and fentanyl as an epidural infusion and thus encountered no hypotension or tachycardia. It is suggested that epidural infusion rather than bolus doses be used in order to avoid epidural block-associated cardiovascular side effects.
The selection of a local anesthetic and dosage thereof is important in neuroaxial block for cardiac patients. Relatively high doses of a local anesthetic may cause severe cardiovascular complications in these patients. Bupivacaine, which is frequently used in epidural anesthesia or analgesia, is a potent local anesthetic, high doses of which may cause severe hemodynamic side effects in cardiac patients. However, ropivacaine is better tolerated than bupivacaine in patients with cardiovascular disease. Knudsen et al. [10] stated that ropivacaine was less neurotoxic and cardiotoxic than bupivacaine. We therefore used ropivacaine in diluted form for our patient. On the other hand, ropivacaine causes less motor block than bupivacaine or other local anesthetics. This property of ropivacaine provides a great advantage in allowing sufficient effort for delivery. In the presence of motor block, the second stage lasts longer than estimated.
Oxytocin is frequently used to enhance postpartum uterine contraction. However, the administration of an intravenous oxytocin bolus has resulted in severe hypotension and tachycardia due to its direct relaxing effect on vascular smooth muscle [9] . These changes can be catastrophic in the presence of both aortic stenosis and insufficiency. Thus, if oxytocin administration is required, it must not be administered as an intravenous bolus to avoid these likely catastrophic effects. We administered 10 IU of oxytocin as an infusion over 1 h, and encountered no side effect resulting from it.
Generally, primigravid patients experience a 25-40% cesarean section rate depending on the institution. In such a case, we planned epidural anesthesia with further 15 ml of 0.125% ropivacaine epidural bolus injection for cesarean section, if there was time to perform the blockade. In case of a blockade failure or emergency cesarean section, general anesthesia was planned and discussed with the patient in advance to cover such contingencies. A management plan to correct her severe disease prior to further pregnancies was made, including close anesthetic, cardiologic and gynecologic evaluation.
Conclusion
This case showed that in spite of the cardiac pathology, vaginal delivery under low-dose slow infusion of epidural analgesia was successful and therefore may be a safe alternative to cesarean section for cardiac patients.
